首页|血清Bcl-2和Bax水平预测肺癌化疗患者发生肺部感染的价值

血清Bcl-2和Bax水平预测肺癌化疗患者发生肺部感染的价值

扫码查看
目的 探讨血清B淋巴细胞瘤基因-2蛋白(Bcl-2)、B淋巴细胞瘤基因-2相关X蛋白(Bax)水平预测肺癌化疗患者发生肺部感染的价值,为临床提供参考.方法 回顾性分析上海大学附属南通医院2021年5月-2023年5月接受化疗的253例肺癌患者的临床资料,根据化疗后是否发生肺部感染分为感染组45例、非感染组208例.比较两组化疗前、化疗后2、4周血清Bcl-2、Bax水平,分析肺癌患者化疗后肺部感染的影响因素,并采用受试者工作特征(ROC)曲线分析血清Bcl-2、Bax水平的预测价值,分析血清Bcl-2、Bax水平与肺部感染影响因素的相关性.结果 感染组化疗后2、4周时血清Bcl-2均明显低于未感染组(t=6.627、7.564),血清Bax均明显高于未感染组(t=7.810、8.253),差异均有统计学意义(P均<0.05).多因素logistic回归分析显示,年龄、吸烟、TNM分期、化疗药物种类、化疗前白蛋白、Ⅲ~Ⅳ度中性粒细胞减少、白细胞计数(WBC)、临床肺部感染评分(CPIS)均是肺癌患者化疗后肺部感染的影响因素(P均<0.05).血清Bcl-2、Bax联合检测的曲线下面积(AUC)为0.912,95%CI为0.865~0.958,均高于血清 Bcl-2(AUC:0.774,95%C/:0.702~0.846)、Bax(AUC:0.827,95%CI:0.770~0.884),且联合检测的敏感度、特异度为81.50%、91.10%,均高于血清Bcl-2单独检测的51.10%、90.40%,及血清Bax单独检测的88.90%、63.00%.Pearson相关性分析显示,血清Bcl-2、Bax与年龄、吸烟、TNM分期、化疗药物种类、化疗前白蛋白、Ⅲ~Ⅳ度中性粒细胞减少、WBC、CPIS评分均具有相关性(P均<0.05).结论 肺癌化疗患者发生肺部感染的影响因素较多,联合检测血清Bcl-2、Bax水平有助于预测肺部感染的发生,应予以密切关注.
The value of serum Bcl-2 and Bax levels in predicting pulmonary infection in patients with lung cancer undergoing chemotherapy
Objective To study the value of serum B cell lymphoma-2 protein(Bcl-2)and B cell lymphoma-2-associated X protein(Bax)levels in predicting pulmonary infection in patients with lung cancer undergoing chemotherapy.Methods Clinical data of 253 patients with lung cancer who received chemotherapy in the Nantong Hospital Affiliated to Shanghai University from May 2021 to May 2023 were retrospectively analyzed;according to whether pulmonary infection occurred after chemotherapy,they were divided into infected group(n=45)and non-infected group(n=208).The serum Bcl-2 and Bax levels were compared between the two groups before chemotherapy,after chemotherapy for 2 and 4 weeks,and the influence factors of lung cancer patients with lung infection after chemotherapy were analyzed;the predictive value of serum Bcl-2 and Bax levels was analyzed by receiver operating characteristic(ROC);the correlation between serum Bcl-2 and Bax levels and influence factors of pulmonary infection was analyzed.Results The serum Bcl-2 levels after chemotherapy for 2 weeks and 4 weeks in the infected group were significantly lower than those in the uninfected group(t=6.627,7.564),and the serum Bax levels were significantly higher than those in the uninfected group(t=7.810,8.253)(all P<0.05).Logistic regression analysis showed that age,smoking,TNM stage,type of chemotherapy drugs,pre-chemotherapy albumin and grade Ⅲ to Ⅳ neutropenia,white blood cell count(WBC)and clinical pulmonary infection score(CPIS)were all influence factors for pulmonary infection in lung cancer patients after chemotherapy(all P<0.05).The area under the curve(AUC)of serum Bcl-2 and Bax combined detection was 0.912 and 95%CI was 0.865-0.958,which were higher than those of serum Bcl-2(AUC:0.774,95%CI:0.702-0.846)and Bax(AUC:0.827,95%CI:0.770-0.884),and the sensitivity and specificity of combined detection were 81.50%and 91.10%,respectively,which were higher than 51.10%and 90.40%of serum Bcl-2 alone and 88.90%and 63.00%of serum Bax alone.Pearson correlation analysis showed that serum Bcl-2 and Bax were correlated with age,smoking,TNM stage,chemotherapy drug type,pre-chemotherapy albumin,grade Ⅲ to Ⅳneutropenia,WBC and CPIS scores(all P<0.05).Conclusion There were many influence factors for lung infection in lung cancer patients undergoing chemotherapy,and the combined detection of serum Bcl-2 and Bax levels could be used to predict the occurrence of lung infection,and should be paid close attention to.

Lung cancerChemotherapyLung infectionBcl-2Bax

魏延梅、魏雅静

展开 >

上海大学附属南通医院(南通市第六人民医院)病理科,江苏南通 226001

上海大学附属南通医院(南通市第六人民医院)检验科,江苏南通 226001

肺癌 化疗 肺部感染 B淋巴细胞瘤基因-2蛋白 B淋巴细胞瘤基因-2相关X蛋白

2024

热带医学杂志
广东省寄生虫学会 中华预防医学会

热带医学杂志

CSTPCD
影响因子:0.643
ISSN:1672-3619
年,卷(期):2024.24(11)